MedMira Inc (MMIRF)
0.0866
0.00 (0.00%)
USD |
OTCM |
Jun 24, 16:00
MedMira Enterprise Value: 65.35M for June 24, 2024
Enterprise Value Chart
Historical Enterprise Value Data
Date | Value |
---|---|
June 24, 2024 | 65.35M |
June 21, 2024 | 65.35M |
June 20, 2024 | 13.78M |
June 18, 2024 | 13.78M |
June 17, 2024 | 41.92M |
June 14, 2024 | 13.71M |
June 13, 2024 | 13.71M |
June 12, 2024 | 13.71M |
June 11, 2024 | 39.67M |
June 10, 2024 | 39.67M |
June 07, 2024 | 39.67M |
June 06, 2024 | 39.67M |
June 05, 2024 | 39.67M |
June 04, 2024 | 39.67M |
June 03, 2024 | 46.69M |
May 31, 2024 | 46.69M |
May 30, 2024 | 46.69M |
May 29, 2024 | 46.69M |
May 28, 2024 | 46.69M |
May 24, 2024 | 46.69M |
May 23, 2024 | 46.69M |
May 22, 2024 | 46.69M |
May 21, 2024 | 46.69M |
May 20, 2024 | 46.69M |
May 17, 2024 | 46.69M |
Date | Value |
---|---|
May 16, 2024 | 46.69M |
May 15, 2024 | 46.69M |
May 14, 2024 | 46.69M |
May 13, 2024 | 46.69M |
May 10, 2024 | 46.69M |
May 09, 2024 | 46.69M |
May 08, 2024 | 46.69M |
May 07, 2024 | 46.69M |
May 06, 2024 | 46.69M |
May 03, 2024 | 46.69M |
May 02, 2024 | 46.69M |
May 01, 2024 | 46.69M |
April 30, 2024 | 46.69M |
April 29, 2024 | 46.69M |
April 26, 2024 | 46.69M |
April 25, 2024 | 46.69M |
April 24, 2024 | 46.69M |
April 23, 2024 | 46.69M |
April 22, 2024 | 46.69M |
April 19, 2024 | 46.69M |
April 18, 2024 | 46.69M |
April 17, 2024 | 46.69M |
April 16, 2024 | 46.69M |
April 15, 2024 | 46.69M |
April 12, 2024 | 46.69M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
6.546M
Minimum
Sep 13 2019
333.86M
Maximum
May 27 2020
77.00M
Average
57.32M
Median
Aug 05 2022
Enterprise Value Benchmarks
Acasti Pharma Inc | 7.073M |
Aurinia Pharmaceuticals Inc | 458.29M |
Edesa Biotech Inc | 11.27M |
Lexaria Bioscience Corp | 28.98M |
Xenon Pharmaceuticals Inc | 2.124B |
Enterprise Value Related Metrics
Net Income (Quarterly) | -0.4374M |
Revenue (Quarterly) | 0.1101M |
Total Expenses (Quarterly) | 0.3826M |
EPS Diluted (Quarterly) | -0.0007 |
Gross Profit Margin (Quarterly) | 45.82% |
Profit Margin (Quarterly) | -397.3% |
Earnings Yield | -3.68% |
Normalized Earnings Yield | -3.682 |